Form 4: NeueHealth Goes Private: NEA 15 Exits Common Stock

New Enterprise Associates 15, L.P. reported the disposition of all its common stock in NeueHealth, Inc. following a merger where the company became a wholly-owned subsidiary.

Summary

• New Enterprise Associates 15, L.P. (NEA 15), a 10% owner and director of NeueHealth, Inc., reported multiple transactions on October 2, 2025.
• These transactions included the exercise of warrants to acquire 189,195 shares and 434,297 shares of common stock at an exercise price of $0.01 per share.
• NEA 15 also disposed of 280 and 643 shares of common stock through cashless net exercises of warrants, based on a fair market value of $6.75 per share.
• The most significant event was the disposition of all 1,960,591 beneficially owned shares of NeueHealth Common Stock.
• This disposition occurred as part of a merger where NeueHealth, Inc. became a wholly-owned subsidiary of NH Holdings 2025, Inc.
• NEA 15 contributed its shares to NH Holdings 2025 SPV, L.P. in exchange for limited partnership interests, and the shares were subsequently cancelled.

Sentiment

Score: 7

Explanation: The filing details a structured exit for a significant insider via a merger, converting public equity into private limited partnership interests. This represents a significant change in ownership structure, which is generally neutral to positive for the reporting entity, but implies a forced exit for other public shareholders.

Positives

• The reporting person, a significant investor, participated in the merger, indicating a structured exit or transition of their investment.
• Warrants were exercised, converting potential equity into actual shares before the merger, suggesting value realization for the reporting person.

Negatives

• Public shareholders (if any remain after the merger) would no longer hold common stock in NeueHealth, Inc. as it became a wholly-owned subsidiary.
• The common stock ceased to exist as a publicly traded security for the reporting person.

Risks

• For public investors, the merger means the loss of direct equity ownership in NeueHealth, Inc. and a forced exit from their investment.
• The value of the limited partnership interests received by the reporting person is subject to the performance of the new private entity.

Future Outlook

NeueHealth, Inc. has become a wholly-owned subsidiary, implying it is no longer a publicly traded entity. The reporting person now holds limited partnership interests in the ultimate parent company, shifting their investment from public equity to a private structure.

Management Comments

• The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest.

Industry Context

This transaction reflects a trend of private equity firms or strategic buyers taking public companies private, often to restructure, integrate, or realize long-term value away from public market pressures. For the healthcare industry, this could signify a strategic consolidation or a move to optimize operations without quarterly reporting scrutiny.

Comparison to Industry Standards

• Cashless net exercise of warrants is a standard practice for insiders to realize value from derivative securities.
• The acquisition of a public company by a private entity, resulting in its delisting, is a common M&A strategy, often employed for strategic control or perceived undervaluation. Specific comparable companies or projects are not detailed in this filing.

Corporate Governance

Related Party Transactions

• The reporting persons (New Enterprise Associates 15, L.P. and NEA Partners 15, L.P.) are identified as directors and 10% owners of NeueHealth, Inc., making their transactions with the issuer related-party transactions.
• The contribution of shares to NH Holdings 2025 SPV, L.P. in exchange for limited partnership interests, as part of the merger, constitutes a related-party transaction given the reporting persons' director/owner status and involvement in the merger agreement.

Stakeholder Impact

• Shareholders: Existing public shareholders of NeueHealth, Inc. would have had their shares acquired or converted as part of the merger, losing direct equity ownership in the company. The reporting person, a significant shareholder, converted their equity into limited partnership interests.
• Employees: No direct impact on employees is mentioned in the filing, but a change in ownership structure can sometimes lead to strategic shifts that may affect employees.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is mentioned in the filing.

Next Steps

• The reporting person will hold limited partnership interests in NH Holdings 2025 SPV, L.P.
• NeueHealth, Inc. will operate as a wholly-owned subsidiary of NH Holdings 2025, Inc.

Key Dates

Recommendation

The filing indicates that NeueHealth, Inc. has completed a merger and become a wholly-owned subsidiary, with all common stock beneficially owned by the reporting person being contributed and cancelled. This implies the company is no longer publicly traded. For any remaining public shareholders, the appropriate action would be to sell their shares as part of the merger terms, as the stock will cease to exist or trade publicly.

Keywords

NeueHealth, NEUE, Merger, Acquisition, Form 4, Insider Transaction, Beneficial Ownership, Warrant Exercise, Private Equity, New Enterprise Associates